Concerning the potential diagnostic clinical use of TOX immunostaining for cutaneous T-cell lymphomas, the presence of TOX-expression in reactive T cells present in inflammatory cutaneous disorders also prevents its diagnostic use for the recognition of MF. The gene discussed is TOX; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.